Please login to the form below
CEPI
This page shows the latest CEPI news and features for those working in and with pharma, biotech and healthcare.
Moderna and Gavi update COVAX supply deal to include variant-specific COVID-19 vaccines
Co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi and the World Health Organization, the COVAX initiative aims to ensure ‘fair and equitable access’ to COVID-19 vaccines for
Latest news
-
100,000 doses of Janssen’s COVID-19 delivered to Ukraine under COVAX initiative
Co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), the Global Alliance for Vaccines and Immunization (GAVI) and WHO, the COVAX initiative aims to ensure ‘fair and equitable access’ to
-
GSK/SK bioscience COVID-19 vaccine to enter phase 3 trial
for Epidemic Preparedness Initiative (CEPI) as part of the ‘Wave 2’ vaccine investment project to develop more accessible and affordable COVID-19 vaccines.
-
South Korean company SK bioscience moves into phase 3 trials for its COVID-19 vaccine
GBP510 is a frontrunner in the Wave 2 vaccine programme run by CEPI – the Coalition for Epidemic Preparedness Innovations – a global partnership between public, private, philanthropic and civil society organisations launched ... SK bioscience has
-
China’s Sinopharm given WHO emergency use listing for COVID-19 vaccine
COVAX is the vaccine pillar of the WHO’s ACT Accelerator – a collaborative initiative co-led by Gavi, the WHO and the Coalition for Epidemic Preparedness Innovations (CEPI) that is working
-
WHO to review Moderna’s COVID-19 vaccine for emergency use listing this week
COVAX is the vaccine pillar of the WHO’s ACT Accelerator – a collaborative initiative co-led by Gavi, the WHO and the Coalition for Epidemic Preparedness Innovations (CEPI) that is working
More from news
Approximately 3 fully matching, plus 22 partially matching documents found.
Latest Intelligence
-
Developing a COVID-19 vaccine
In March the CEPI called for new funding for the expansion of potential vaccine candidates, saying that $2bn is needed to support the development of a successful COVID-19 vaccine. ... stockpiled and ready for trials and emergency authorisation should an
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
What does the COVID-19 vaccine mean for the future of R&D?
The Coalition for Epidemic Preparedness Innovation (CEPI), for example, has been supporting the development of vaccines against five emerging pathogens on the World Health Organization priority list, since its genesis in ... 2017. CEPI also supports the
-
Is the world ready for a COVID-19 vaccine?
One of the ways the world is looking to mitigate this is through the COVAX initiative, which is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), the Global Alliance
-
Understanding COVID-19 and varying responses across the globe
The Coalition for Epidemic Preparedness Innovation (CEPI), a global alliance financing and coordinating the development of vaccines against emerging infectious diseases, launched in 2017 and is needed now more than ever.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Roche’s Polivy recommended by NICE for lymphoma therapy
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
- Gilead’s Trodelvy approved by FDA for metastatic breast cancer
- World Health Organization releases new road map for breast cancer
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- Making new year resolutions that can also benefit others
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- Omnichannel communications in Medical Affairs: closing the gap between aspiration and reality
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Meeting healthcare’s rising challenges
- Why female mentorship is so powerful in pharma
- AZ’s COVID-19 vaccine trial to continue after Brazilian volunteer death
PMHub
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
